Presentation and Management of Cutaneous Manifestations of COVID-19.
CONCLUSIONS: Cutaneous symptoms are part of the COVID-19 disease spectrum. Early identification, diagnosis, and management through a multidisciplinary approach can facilitate safe disease resolution for patients. J Drugs Dermatol. 2021;20(1):76-83. doi:10.36849/JDD.2021.5676.
PMID: 33400417 [PubMed - as supplied by publisher]
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research
More News: Alopecia | Coronavirus | COVID-19 | Dermatology | Hives | Laboratory Medicine | Respiratory Medicine | SARS | Skin | Skin Biopsy